← Human Trials & Peer-Reviewed Studies

Neuroticism modulates the effects of intranasal vasopressin treatment on the neural response to positive and negative social interactions

Plain-language guide to PMID 25979609 (2015): double-blind randomized controlled trial study of Oxytocin and Vasopressin in 153 participants.

Key Facts

PMID
25979609
Journal
Neuropsychologia
Year
2015
Study type
Randomized Controlled Trial
Authors
Feng C et al. (4 authors)
DOI
10.1016/j.neuropsychologia.2015.05.004

What This Study Did, in Plain Language

What Was Tested

The paper reports a study of Oxytocin and Vasopressin, published as a randomized controlled trial.

Here the researchers ask how Neuroticism influences the neural response to positive and negative social interactions and how Neuroticism modulates the effect of intranasal oxytocin (OT) and vasopressin (AVP) on the neural response to social interactions.

Afterwards, they were imaged with fMRI while playing an iterated Prisoner's Dilemma Game.

Who Took Part

The study group was 153 participants.

The age groups tagged for this paper are teenagers and young adults, men only.

How the Study Was Run

The design is described as randomized, double-blind and placebo-controlled.

The participants were allocated by chance, so the Oxytocin group and the comparison group should start out alike.

Blinding on both sides kept the participants and researchers unaware of who received Oxytocin.

The comparison arm used a placebo, so changes seen with Oxytocin could be set against what happens without it.

What Was Measured

On a different day, subjects completed the NEO personality inventory to measure Neuroticism.

Topics PubMed links to this paper include Anxiety Disorders, Brain, Brain Mapping, Cerebrovascular Circulation, Emotions, Interpersonal Relations and Magnetic Resonance Imaging.

The authors tagged it with the keywords Cooperation, Neuroticism, Oxytocin, Vasopressin and fMRI.

What This Means in Plain Language

The paper is a randomized, double-blind and placebo-controlled study of Oxytocin and Vasopressin in 153 participants.

The publication is from 2015 (Neuropsychologia), a journal based in England.

More context: the Oxytocin compound page and the Vasopressin compound page, all human trials.

Our Notes on the Compounds

Oxytocin: A peptide hormone with established obstetric medical uses and a less settled role in research on behavior, sexual function and appetite.

Vasopressin: A 9-amino-acid hormone (antidiuretic hormone) that controls water balance and blood vessel tone; used in septic shock.

Related Pages

Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.